MD EBITDA Growth
Pediatrix Medical Group Inc · EBITDA Growth
MD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported31.21%period ending
MD TTM EBITDA YoY % (182.95% → 31.21%)
Year-over-year change
High-resolution chart · PNG
MD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 31.2121% | |
| 2,020.5135% | |
| 1,045.7952% | |
| 230.4541% | |
| 207.5724% | |
| -178.2578% | |
| -194.9309% | |
| -200.7552% | |
| -193.0036% | |
| -90.9234% | |
| -80.9274% | |
| 4.6547% | |
| 1.9062% | |
| 1.1084% | |
| -33.6286% | |
| -7.7181% | |
| 15.5447% | |
| 30.4297% | |
| 61.6317% | |
| 15.4073% | |
| -21.0341% | |
| -44.0343% | |
| -56.4% | |
| -55.495% | |
| -52.0377% | |
| -45.6962% | |
| -41.1089% | |
| -32.2007% | |
| -23.3247% | |
| -12.7559% | |
| -2.4129% | |
| -2.4334% | |
| -5.3297% | |
| -9.8486% | |
| -11.8006% | |
| -9.5401% | |
| -3.1744% | |
| 1.7734% | |
| 6.2458% | |
| 8.694% | |
| 9.902% | |
| 10.955% | |
| 10.975% | |
| 12.6471% | |
| 12.4927% | |
| 13.084% | |
| 13.3169% | |
| 14.9721% | |
| 16.0743% | |
| 16.4214% | |
| 17.1619% | |
| 14.7824% | |
| 14.3249% | |
| 12.6839% | |
| 10.481% | |
| 9.2713% | |
| 9.4285% | |
| 10.8456% | |
| 13.6431% | |
| 14.1705% | |
| 11.9154% | |
| 10.9039% | |
| 9.4258% | |
| 11.1256% | |
| 16.0666% | |
| 19.4577% | |
| 19.3151% | |
| 18.5768% | |
| 12.1482% | |
| 8.5348% | |
| 12.9328% | |
| 14.7258% | |
| 17.2237% | |
| 16.8154% | |
| 9.5565% | |
| 16.154% | |
| 20.9988% | |
| 25.7632% | |
| 32.4267% | |
| 11.5271% | |
| 6.1821% | |
| 2.6654% | |
| -5.0545% | |
| 2.2075% | |
| 2.3843% | |
| 5.6268% | |
| 13.9593% | |
| 20.0875% | |
| 25.0185% | |
| 23.2556% | |
| 22.9107% | |
| 22.5894% | |
| 22.8808% | |
| 33.0817% | |
| 47.9894% | |
| 67.7781% | |
| 100.7243% | |
| 139.1512% | |
| 106.4991% | |
| 68.6126% |